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the integrated management of the ischemic
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Rosa Cervelli, MD,a Elisabetta Iacopi, MD,b Alessandro Lunardi, MD,a and Roberto Cioni, MD,a Pisa, Italy
Objective: To retrospectively evaluate the agreement between the angiographic scores and the clinical outcomes after
endoluminal revascularization in diabetic patients with Fontaine stage IV critical limb ischemia (CLI).
Methods: Clinical and procedural data were retrospectively collected of consecutive diabetic patients with Fontaine stage IV
CLI who underwent percutaneous lower limb endoluminal revascularization from January 2009 to June 2011. Pre- and
postprocedural angiographic images were retrospectively reviewed to classify lower limb arterial involvement according to
four systems: (1) TransAtlantic Inter-Society Consensus [TASC] I; (2) TASC II; (3) Graziani’s morphologic classiﬁca-
tion; and (4) Joint Vascular Society Council calf and foot scores. Foot lesions were graded according to the University of
Texas wound classiﬁcation system. Clinical results (healing, nonhealing, or major amputation) were compared with
baseline clinical data and angiographic results.
Results: In the study period, 202 percutaneous procedures were performed, with an immediate technical success rate of
94%. Preprocedurally, the mean ± standard deviation calf and foot scores were 7.8 ± 1.6 and 7.3 ± 2.3, respectively; 132
patients (65%) were in Graziani’s morphologic classes from 4 to 7; in 112 (55%) cases, TASC II was considered inap-
plicable, for the absence of femoropopliteal lesions; and ﬁnally, 93% of limbs were classiﬁed as TASC I type D lesions.
After the procedure, mean calf and foot scores were 4.8 ± 2.3 and 5.9 ± 2.6, respectively, and 87% of cases were in
Graziani’s classes 1 and 2; TASC II was inapplicable in all cases, whereas 80% of cases remained TASC I type D lesions.
Healing rate was 67% and major amputation rate was 4%. Among all the clinical and angiographic variables included in
the analysis, only pre- and postprocedural foot scores were signiﬁcantly associated to the clinical outcome (P < .05).
Conclusions: Endoluminal revascularization represents a valuable treatment option in diabetic patients with CLI. TASC
classiﬁcations are inadequate to describe peripheral arterial involvement in the vast majority of diabetic patients with CLI.
Pre- and postprocedural foot scores represent the most signiﬁcant angiographic parameters to evaluate treatment
success. (J Vasc Surg 2013;57:1204-12.)Lower limb peripheral arterial disease (PAD) is a
common complication of diabetes mellitus and is associated
with more severe clinical manifestations and a higher risk of
critical limb ischemia (CLI) and limb loss in diabetic
patients. Recent studies have demonstrated the beneﬁts
derived frompercutaneous revascularization of ischemic dia-
betic foot, with high technical and clinical success rates.1-7
The increasing role of percutaneous procedures in
this patient population has raised the issue of the lack
of uniform morphologic criteria able to adequately
describe the degree of involvement of the peripheral vascular
system.8 In fact, the international guidelines, produced by
the Intersociety Consensus for the Management of Periph-
eral Arterial Disease (TransAtlantic Inter-Society Consensusthe Department of Diagnostic and Interventional Radiology,a and
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4[TASC] II),9 do not provide an adequate description of
infrapopliteal PAD and, therefore, they are not useful in
the diabetic population. In a review of 417 consecutive dia-
betic patients with PAD, Graziani et al proposed a more
speciﬁc morphologic classiﬁcation based on the infrapopli-
teal arterial involvement in diabetic foot ischemia and proved
a signiﬁcant correlation between this classiﬁcation and the
clinical severity of the disease.10 Moreover, recent papers
have demonstrated the need to focus the treatment speciﬁ-
cally on the wound-related artery, to allow direct arterial
ﬂow to the lesion and ultimately to improve the clinical
result, the so-called “angiosome model.”11-13
The aim of this study was to retrospectively evaluate
the relationship between the clinical data (in terms of lesion
severity and clinical success after treatment) and the
vascular involvement, evaluated before and after treatment
at digital subtraction angiography (DSA), in a homoge-
neous series of diabetic patients with critically ischemic
foot, consecutively treated with percutaneous endoluminal
revascularization.
METHODS
We retrospectively collected the data of all diabetic
patients with CLI who underwent infrainguinal percuta-
neous revascularization between January 2009 and June
Table I. Graziani’s classiﬁcation of below-the-knee
arterial lesions10
Class Angiographic ﬁnding
1 Isolated, one vessel tibial or peroneal artery obstruction
2a Isolated femoral/popliteal artery or two below-knee
arteries obstructed but with patency of one of the
two tibial arteries
2b Isolated femoral/popliteal artery or two below-knee
tibial arteries obstructed but with patency of the
peroneal artery
3 Isolated, one artery occluded and multiple stenosis
of tibial/peroneal and/or femoral/popliteal arteries
4 Two arteries occluded and multiple stenosis of tibial/
peroneal and/or femoral/popliteal vessels
5 Occlusion of all tibial and peroneal arteries
(below knee cross-sectional occlusion)
6 Three arteries occluded and multiple stenosis of tibial/
peroneal and/or femoral/popliteal arteries
7 Multiple femoropopliteal obstructions with no visible
below-the-knee arterial segments
Table II. Joint Vascular Societies Council
classiﬁcation19,20
Score Angiographic ﬁnding
0 Stenosis less than 20%
1 20%-49% stenosis
2 50%-99% stenosis
2.5 Occlusion of less than one-half the total length of
the vessel
3 Occlusion of more than one-half the total length of
the vessel
Table III. Patients’ demographic and clinical data at the
time of each procedure (202 lower limbs)
Variable No.
Age, years (mean 6 SD) 71.8 6 9.8 (range, 39-89)
Sex (M/F) 142/60
Comorbidity
Coronary artery disease 65 (32%)
Other cardiac disease 44 (22%)
Cerebrovascular disease 22 (11%)
Hypertension 124 (61%)
Retinopathy 107 (53%)
Nephropathy 65 (32%)
Neuropathy 33 (16%)
Charcot 10 (5%)
HbA1c, % (mean 6 SD) 7.8 6 1.8 (range, 0.9-14.5)
Serum creatinine,
mg/dL (mean 6 SD)
1.68 6 1.9 (range, 0.5-13.4)
Diabetes type 1/2 3/199
Diabetes duration, years
(mean 6 SD)
20.5 6 12.1 (range, 0.1-47)
More than one foot lesion 21 (10%)
Foot lesion duration, weeks
(mean 6 SD)
16 6 24 (range, 1-192)
University of Texas wound
classiﬁcation
I-C 43 (21%)
II-C 10 (5%)
III-C 46 (23%)
I-D 6 (3%)
II-D 9 (4%)
III-D 88 (44%)
Lesion site (n ¼ 221)
Midfoot 6 (3%)
Hindfoot 24 (11%)
Leg 17 (7%)
HbA1c, Hemoglobin A1c; SD, standard deviation.
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sity of Pisa hospital. CLI was deﬁned by the presence of
ulcers or gangrene and/or ischemic rest pain, according to
the TASC II deﬁnition.9 All patients underwent preproce-
dural color-coded duplex ultrasound of the peripheral
arteries, to assess patency of inﬂow and outﬂow vessels.
Technique of endovascular revascularization. In-
formed written consent was obtained for endovascular
treatment and for any procedure required to achieve
wound healing. Endovascular revascularization was per-
formed with an antegrade ispilateral puncture of the
common femoral artery (4- to 5F introducer sheath),
under local anaesthesia; in selected cases in which the
ispsilateral approach was considered unfeasible or contrain-
dicated (for example, occlusion of the origin of the super-
ﬁcial femoral artery), a contralateral retrograde access was
chosen, followed by the cross-over of the iliac axis.
Before treatment, DSA (Innova 4100; GE Healthcare,
Milwaukee, Wis) of the affected limb arteries was obtained.
After intra-arterial administration of a bolus of heparin
(5000 IU), stenoses were crossed using .014- to .035-inch
hydrophilic guidewires and treated by transluminal
angioplasty using 3- to 6-mm balloon catheters with vari-
able lengths, depending on the target vessels. Wheneverpossible, endoluminal treatment was performed following
the angiosome-model approach (ie, targeting the revascu-
larization primarily to the artery providing direct blood
ﬂow to the wound-related area)13; the target vessel was
identiﬁed on the basis of the initial angiogram and the
treating physician’s opinion.
Immediate technical success was deﬁned by the pres-
ence of direct blood ﬂow through the treated arteries with
residual stenosis <30% of the vessels’ diameter, in the
absence of immediate complications. Stenting was per-
formed only as salvage strategy, in case of re-coiling or
ﬂow-limiting dissections. No other endovascular devices
were used. In speciﬁc cases, revascularization was performed
by subintimal angioplasty, according to the indications and
technique described by Bolia et al.14,15 Vasodilators were
not administered during the procedure.
Other treatments. After revascularization, all patients
were treated by subcutaneous low molecular weight
heparin (1 mg/kg/d in the ﬁrst week, 0.5 mg/kg/d from
the second to the fourth week), and ticlopidine (250 mg/d)
or acetylsalicylic acid (300 mg/d), lifelong starting from the
second week. Heparin was administered to prevent throm-
bosis in highly thrombophilic patients (such as those with
diabetes, particularly after interventions) who are forced to
Fig 1. Male patient with D3 lesion of the forefoot extended to third, fourth, and ﬁfth toe. The preprocedural angiographic
images (A, thigh level;B, popliteal level;C, calf;D, foot) demonstrate no signiﬁcant involvement of the femoropopliteal axis
and occlusion at different levels of all three infrapopliteal arteries. Thus, patient was not classiﬁable according to Trans-
Atlantic Inter-Society Consensus (TASC) II, and hewas classiﬁed intoGraziani’s class 5,while the calf scorewas 10 (anterior
tibial artery, 3; posterior tibial artery, 3; peroneal artery, 3) and the foot score was 10 (dorsalis pedis artery, 3; lateral plantar
artery, 3; medial plantar artery, 3). Revascularization was attempted of the posterior tibial and peroneal arteries but failed to
achieve a distal re-entry with adequate run-off. Therefore, the ﬁnal angiographic control (E, calf; F, foot) was unchanged
compared with the baseline acquisition. The patient underwent major amputation because of the extensive gangrene 4 days
after the attempted revascularization.
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Table IV. Procedural data
No. (%)
Vascular access
Ipsilateral antegrade 155 (77)
Contralateral retrograde 47 (23)
Subintimal revascularization 27 (14)
Stenting
Iliac 4 (2)
Femoropopliteal 5 (2)
Infrapopliteal 4 (2)
Intra-arterial thrombolysis 5 (2)
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period of time.
When required, foot lesions were surgically treated
(ie, surgical debridement or minor amputations, assisted
wound closure with the application of negative pressure
wound therapy, and dermal substitutes) 2-5 days after
revascularization; acutely infected lesions underwent
surgical treatment the day before percutaneous revascular-
ization as an emergency procedure. Ofﬂoading was guaran-
teed by nonremovable instant contact casting devices.
Major amputations were performed in cases where
revascularization did not lead to a meaningful lesion im-
provement, after surgical evaluation excluding any chance
for bypass surgery.
Postprocedural follow-up. All patients underwent
color-coded duplex ultrasound 24 hours after the proce-
dure. After discharge, regular clinical follow-up (with
different time intervals, depending on each single case) was
performed at the Diabetic Foot Section at the University of
Pisa hospital, for local medications, adaptation of the
systemic antibiotic therapy and of other therapies related to
comorbidities, and glycemic control until complete wound
healing. No other procedures, such as hyperbaric oxygen
therapy, were adopted for wound healing.
Data collection. All preprocedural data were collected
from the clinical ﬁles, with particular reference to age, sex,
comorbidities, diabetes type and duration in years, serum
levels of hemoglobin A1c (HbA1c) and creatinine, lesion
location, and lesion severity according to the University
of Texas (UT) wound classiﬁcation system.16
The angiographic data were collected via the analysis of
the reports and images stored on the computer system of
Radiology Information System-Picture Archiving and
Communication System of the Interventional Radiology
Unit. The data concerning the surgical operations and
the follow-up of patients were collected by the analysis of
the computerized clinical folders, stored on the informa-
tion system E-upodi@ of the Diabetic Foot Clinic at the
University of Pisa hospital.
Evaluation of the clinical results. The clinical
result was deﬁned as healing (complete and durable re-
epithelization of the lesion, according to the International
Consensus on Diabetic Foot17), nonhealing, or major
amputation. Time for healing was calculated from the
time of the revascularization procedure. For each patient,follow-up was censored at the time of lesion healing
or major amputation or, in case of lesion stability, at
March 31, 2012.
Evaluation of the angiographic images. Two inter-
ventional radiologists in consensus reviewed pre- and post-
procedural DSA images of the peripheral arteries and
classiﬁed the arterial involvement, using four different
systems: (1) TASC I classiﬁcation for infrapopliteal
lesions18; (2) TASC II classiﬁcation for femoropopliteal
lesions9; (3) Graziani’s classiﬁcation (Table I)10; and
(4) The Joint Vascular Societies Council classiﬁcation.19,20
This provides a score from 0 to 3 on the basis of the most
severe stenosis (Table II) for each of the following arteries:
anterior tibial, posterior tibial, peroneal including the
tibioperoneal trunk, dorsalis pedis, lateral plantar, and
medial plantar. The dorsalis pedis was evaluated on its
entire length from the ankle joint level to the level at which
it gives off its arcuate branch. A “foot score” (sum of the 3
foot vessels scores plus 1) and a “calf score” (sum of the
3 calf vessels scores plus 1) were ﬁnally obtained.20
Statistical analysis. The data were evaluated via
descriptive statistics (mean, median, and standard deviation)
and compared with the c2 test or Fisher exact test for the
categorical data and the one-way analysis of variance and
Student t-test for the continuous variables. Lesion severity
and clinical results were evaluated in relationship to the
clinical and pre- and postprocedural angiographic variables.
The statistical analysis was performed with the SAS software
(SAS Institute, Cary, NC). A P value of less than .05 was
considered statistically signiﬁcant.
RESULTS
The study included 202 lower limbs treated by percu-
taneous revascularizations in 166 patients (males/females,
115/51; mean age, 72.8 6 9.8 years), with 36 patients
who received treatment of both legs. The clinical and
demographic data, collected at the time of each procedure,
are reported in Table III.
Lesion severity according to the UT wound classiﬁca-
tion system was signiﬁcantly related to patients’ age
(P ¼ .03), diabetic retinopathy (P ¼ .0007), and HbA1c
levels (P ¼ .01) (Table III). In particular, younger patients,
those with poor diabetic control, and patients with
advanced complications of retinopathy presented more
severe ulcerations.
At the preprocedural DSA images, the mean calf score
was 7.8 6 1.6 (median, 8), whereas the mean foot score
was 7.3 6 2.3 (median, 8); at least two calf and foot
obstructed arteries (score 2.5 or 3) were observed in 63%
and in 65% of limbs, respectively. TASC II classiﬁcation
was considered inapplicable in 112/202 (55%) limbs before
the procedure (Fig 1), whereas the vast majority (93%) of
limbs were classiﬁed as having TASC I type D lesions.
Finally, 132 (65%) lower limbs fell within Graziani’s
morphologic classes ranging from 4 to 7 with seven (3%)
cases that were not classiﬁable for the absence of below-
the-knee arterial occlusions. We observed a signiﬁcant
agreement between Graziani’s morphologic classes and
Fig 2. A 64-year-old male patient, with D3 lesion of the third toe. According to the preprocedural angiographic
images (A, thigh level; B, popliteal level; C, calf; D, foot), the patient was classiﬁed as TransAtlantic Inter-Society
Consensus (TASC) II B (for the presence of a focal occlusion of the distal superﬁcial femoral artery, arrow), Graziani’s
class 6, calf score 8 (anterior tibial artery, 2.5; posterior tibial artery, 2.5; peroneal artery, 2), and foot score 9 (dorsalis
pedis artery, 2.5; lateral plantar artery, 3; medial plantar artery, 2.5).
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dural calf and foot scores were statistically lower in II-D
lesions compared with the remaining lesions (P ¼ .002
and P ¼ .03, respectively). Procedural details are reported
in Table IV. The revascularization procedure was techni-
cally successful in 189 cases (94%) (Figs 2 and 3); no
statistical correlation was found between more complex
procedures and angiographic scores. At immediate post-
procedural DSA, the mean calf score was 4.8 6 2.3
(median, 4) with a mean reduction of 3 6 1.9 (range,
0-8), whereas the mean foot score was 5.9 6 2.6 (median,
6.5), with a mean reduction of 1.4 6 1.6 (range, 2.5 to
8). One hundred seventy-ﬁve angiographies (87%) were
classiﬁed in Graziani’s morphologic classes 1 and 2. The
TASC II classiﬁcation was inapplicable in all cases because
of the successful revascularization of the femoropopliteal
axis in all the patients with previous stenoses or occlusions.
Finally, 80% of cases remained classiﬁed as TASC I type
D lesions, showing at least one occluded infrapopliteal
artery.Clinical follow-up was available in 181/202 (90%)
cases, whereas the remaining patients were clinically fol-
lowed in outside institutions. At latest follow-up, 121
(67%) ulcers had healed, after a mean healing time of
28.4 6 23.7 weeks. In 53 cases (29%), the lesion was
not healed, whereas in seven cases (4%), major amputa-
tion was required a mean of 30.7 6 24.6 weeks after
the revascularization procedure. Preprocedural minor
amputations were required in 19 (10%) cases, whereas
postprocedural minor amputations were performed in
59 (33%) cases, a mean of 6 6 5 days after the revascular-
ization procedure.
Among all the clinical and angiographic variables
included in the analysis (Tables V, VI, and VII), the clinical
outcome was signiﬁcantly related only to the foot scores,
with ulcer healing obtained in patients with lower prepro-
cedural (mean score, 7 in healed patients and 7.8 in non-
healed patients; P ¼ .049) and postprocedural (mean
score, 5.5 in healed patients and 6.3 in nonhealed patients;
P ¼ .047) foot scores (Fig 4).
Fig 3. Same patient as Fig 2. The postprocedural angiographic images (A, thigh level; B, popliteal level; C, calf; D,
foot) demonstrate recanalization of femoropopliteal axis and patency of the three calf arteries. Thus, the patient is not
classiﬁable according to TransAtlantic Inter-Society Consensus (TASC) II, and he is in Graziani’s class 0. The calf score
is 1 (anterior tibial artery, 0; posterior tibial artery, 0; peroneal artery, 0), whereas the foot score is 6.5 (dorsalis pedis
artery, 2.5; lateral plantar artery, 3; medial plantar artery, 0). Patient underwent minor amputation of the toe, with
complete wound epithelization after 5 months.
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PAD is a relatively common complication of diabetes
mellitus that can be underestimated, yet is associated with
higher incidence of comorbidities and increased risk of
CLI, major amputation, and death.21 Percutaneous or
surgical revascularization is required to improve patients’
prognosis.
Our retrospective study on diabetic patients with CLI
focused on the possible correlation between severity of
arterial involvement and clinical results. Our baseline clin-
ical data conﬁrmed that diabetic patients with CLI are
aged patients, with multiple comorbidities and systemic
microvascular and macrovascular diseases. Coronary artery
disease was present in about one-third of the patients, 10%
of the population was affected by cerebrovascular disease,
and hypertension was found in over 50% of cases. Among
microvascular complications, diabetic retinopathy was
registered in 53% of patients, nephropathy in 32%, and
neuropathy in 16% of patients.With regard to the limb lesions, the vast majority (76%)
of our patients had either type 2 or 3 lesions according to
the UT wound classiﬁcation system, which means that the
vast majority of the lesions involved the deeper levels.
Lesion severity was in accordance to the degree of arterial
involvement; in fact, the median calf and foot scores were 8
each, with at least two obstructed arteries in over 60% of
the treated limbs. Foot and calf scores were signiﬁcantly
correlated to Graziani’s morphologic classiﬁcation that
has been developed to speciﬁcally represent the arterial
involvement in the diabetic population. In our series, the
majority of patients were in Graziani’s classes 4 to 7,
with percentages of patients in the different classes that
are comparable to those reported by Graziani et al in their
wider cohort of patients.10 However, Graziani’s classiﬁca-
tion does not take into consideration the foot arteries,
whereas, according to our results, the foot score seems to
be the most important parameter related to the clinical
outcome.
Table V. Preprocedural clinical data compared with
clinical outcome (181 treated limbs)
Variable
Healed
(n ¼ 121)
Not healed
(n ¼ 60) P
Age, years (mean 6 SD) 70.7 6 10 73.2 6 8.4 .10
Sex (M/F) 92/29 39/21 .12
Comorbidity
Coronary artery disease 35 (29%) 22 (37%) .29
Other cardiac disease 17 (14%) 14 (23%) .39
Cerebrovascular disease 12 (10%) 9 (15%) .32
Hypertension 68 (57%) 40 (67%) .17
Retinopathy 69 (53%) 31 (52%) .49
Nephropathy 31 (26%) 24 (40%) .08
Neuropathy 18 (15%) 10 (17%) .75
Charcot 7 (6%) 3 (5%) .83
HbA1c, % (mean 6 SD) 8.1 6 1.7 7.7 6 1.8 .22
Creatinine, mg/dL
(mean 6 SD)
1.4 6 1.2 1.8 6 2.2 .09
Diabetes type 1/2 2/119 1/59 .20
Diabetes duration, years
(mean 6 SD)
19.6 6 11.8 22.2 6 12.1 .19
Lesion duration, weeks
(mean 6 SD)
17 6 28 14 6 17 .49
University of Texas Wound
classiﬁcation
C/D 55/66 33/27 .20
I/II/III 28/13/80 15/5/40 .83
Adjunctive procedures 23 (19%) 12 (20%) .87
HbA1c, Hemoglobin A1c; SD, standard deviation.
Adjunctive procedures include subintimal angioplasty, stenting, and intra-
arterial thrombolysis.
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international guidelines providing recommendations for
the treatment of PAD.9 However, the limitations of these
guidelines have been pointed out because of the lack of
a proper description of infrapopliteal arterial involvement
that is prevalent in the diabetic population.22 Our data
demonstrate that TASC II classiﬁcation is inadequate to
describe the arterial involvement in diabetic patients with
CLI because it was inapplicable in more than one-half of
our patients at baseline and in all of them after treatment,
either because of the absence of any femoropopliteal
involvement or the successful percutaneous treatment of
femoropopliteal stenoses, when present. Even the morpho-
logic classiﬁcation of infrapopliteal lesions proposed in the
former TASC I guidelines18 does not adequately stratify
diabetic patients with CLI because it does not take into
account the number of occluded infrapopliteal arteries,
nor does it differentiate between tibial and peroneal
arteries.
In agreement with previous published data,1-7 our
immediate technical success rate of the percutaneous
treatment was 94%, whereas healing rate was almost
70%. Healing time is, however, a major concern. Our
mean healing time was about 6 months, suggesting that
the healing process requires careful follow-up and
a remarkable effort both from the care provider and
from the patient. Efforts should be made to reduce the
healing time by improving revascularization techniques
and patency rates.Our postprocedural angiographic results show a remark-
able reduction in the postprocedural calf scores demon-
strating that at this time, it is possible to recanalize most of
the infrapopliteal arteries, thanks to the reﬁnement of the
devices, with the introduction of low-proﬁle dedicatedmate-
rials. On the other hand, we did not observe a similar reduc-
tion in the postprocedural foot scores. At foot level, heavy
calciﬁcations, long-lasting chronic occlusions, and develop-
ment of multiple tiny collateral arteries might reduce the
technical chances of gaining the complete patency of at least
one entire native foot artery. In these conditions, implement-
ing the blood ﬂow at the level of collateral arteries is often the
only available option.
Our data demonstrate that the preprocedural and
postprocedural foot scores represent important predictive
factors for ulcer healing, whereas the remaining angio-
graphic classiﬁcations were not signiﬁcantly associated to
the clinical outcome. In the present experience, at ﬁnal
angiography, the mean calf score was 4.6, and 61/181
(34%) limbs still presented two (n ¼ 52) or three (n ¼ 9)
occluded calf arteries. Nonetheless a good healing rate and
a low rate of major amputations were registered, indepen-
dently from the number of postprocedural occluded vessels.
This ﬁnding might represent a further conﬁrmation that an
“optimal cosmetic” angiographic result at the calf level
should not represent the goal of the revascularization proce-
dure, whereas efforts should be concentrated on improving
the direct blood ﬂow to the wound-related area.11-13
Attempting recanalization of all the infrapopliteal arteries
may increase the risk of complications because of increased
manipulations and longer procedural time, with no available
proof of a substantial clinical beneﬁt.
Our major amputation rate (about 4%) is lower in
comparison to previous published data.1-7 This result could
be inﬂuenced by the retrospective design of the study that
included only patients who were considered candidates for
percutaneous revascularization. However, the low amputa-
tion rate might also be the result of an aggressive multidisci-
plinary approach to the ischemic diabetic foot in the setting
of a dedicated Diabetic Foot Care Unit. Ulcer healing
depends on many variables, such as patient age, presence of
comorbidities, glyco-metabolic control, lesion size, and
duration,7 as well as patients’ compliance to treatment and
prevention. In other words, the “diabetic foot” is a complex
multifactorial disease that requires the organization of
a dedicated multidisciplinary team for patients’ preproce-
dural evaluation, treatment, and follow-up.23,24
The main limitation of the study is the lack of physio-
logical evaluation of the pre- and postprocedural perfusion
of the extremities because of the absence of TcPO2 values
in all patients. Nonetheless, the objective of the study was
to analyze the role of morphologic data in the assessment
of the clinical outcome in this selected series of patients.
In conclusion, the percutaneous revascularization
represents a valuable treatment option in diabetic patients
with CLI. TASC classiﬁcations are inadequate to describe
PAD and to provide treatment guidelines in the diabetic
population. The foot score represents the most signiﬁcant
Table VI. Preprocedural angiographic scores compared with clinical outcome (181 treated limbs)
Total Healing (n ¼121) Nonhealing (n ¼ 60) P
TASC I .64
A 2 2 (100%) 0 (0%)
B 3 2 (67%) 1 (33%)
C 7 5 (71%) 2 (29%)
D 169 112 (67%) 57 (33%)
TASC II .31
B 56 40 (71%) 16 (29%)
C 1 0 1 (100%)
D 21 12 (57%) 9 (43%)
NA 103 69 (67%) 34 (33%)
Graziani classiﬁcation .89
1 4 3 (75%) 1 (25%)
2a 4 3 (75%) 1 (25%)
2b 4 3 (75%) 1 (25%)
3 47 34 (72%) 13 (28%)
4 59 36 (61%) 23 (39%)
5 14 11 (79%) 3 (21%)
6 38 24 (63%) 14 (37%)
7 4 2 (50%) 2 (50%)
NA 7 5 (71%) 2 (20%)
Calf score (mean 6 SD) 7.7 6 1.7 7.5 6 1.8 8.0 6 1.5 .07
No occludeda calf arteries (mean 6 SD) 1.8 6 0.9 1.74 6 0.8 1.9 6 0.9 .25
Foot score (mean 6 SD) 7.3 6 2.4 7.0 6 2.5 7.8 6 2.0 .049
No occludeda foot arteries (mean 6 SD) 1.8 6 1.1 1.7 6 1.1 1.9 6 1.0 .46
NA, Not applicable; SD, standard deviation; TASC, TransAtlantic Inter-Society Consensus.
When not otherwise speciﬁed, data are given as numbers (%).
aOccluded arteries: corresponding to scores 2.5 or 3.
Table VII. Postprocedural angiographic scores compared with clinical outcome (181 treated limbs)
Total Healing (n ¼ 121) Nonhealing (n ¼ 60) P
TASC I .48
A 31 22 (71%) 9 (29%)
B 1 0 1 (100%)
C 6 4 (67%) 2 (33%)
D 143 95 (66%) 48 (34%)
TASC II NA
B 0 0 0
C 0 0 0
D 0 0 0
NA 181 121 (67%) 60 (33%)
Graziani classiﬁcation .31
0 31 21 (68%) 10 (32%)
1 79 54 (68%) 25 (32%)
2a 27 15 (55%) 12 (45%)
2b 23 19 (83%) 4 (17%)
3 7 4 (57%) 3 (43%)
4 4 2 (50%) 2 (50%)
5 4 1 (25%) 3 (75%)
6 3 2 (67%) 1 (33%)
7 1 1 (100%) 0
NA 2 2 (100%) 0
Calf score (mean 6 SD) 4.6 6 2.3 4.5 6 2.2 4.8 6 2.4 .38
No occludeda calf arteries (mean 6 SD) 1.2 6 0.8 1.2 6 0.8 1.3 6 0.9 .39
D calf score pre  post (mean 6 SD) 3.1 6 2 3 6 2 3.2 6 2 .57
Foot score (mean 6 SD) 5.8 6 2.6 5.5 6 2.7 6.3 6 2.3 .047
No occludeda foot arteries (mean 6 SD) 1.5 6 1.1 1.4 6 1.1 1.5 6 1 .50
D foot score pre  post (mean 6 SD) 1.5 6 1.6 1.5 6 1.7 1.4 6 1.4 .77
NA, Not applicable; SD, standard deviation; TASC, TransAtlantic Inter-Society Consensus; D, difference.
When not otherwise speciﬁed, data are given as numbers (%).
aOccluded arteries: corresponding to scores 2.5 or 3.
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 5 Bargellini et al 1211
Fig 4. Clinical success according to preprocedural and post-
procedural calf and foot scores (box plot). Distribution of pre- and
postprocedural calf and foot scores according to the clinical
success. Only the foot scores were signiﬁcantly related to wound
healing (one-way analysis of variance).
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1212 Bargellini et al May 2013angiographic parameter to evaluate treatment success and
chances for ulcer healing. Prospective studies are warranted
to evaluate the role of the angiographic scores in addressing
the most proper treatment approach in the diabetic
population.
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